Amended Statement of Beneficial Ownership (sc 13d/a)
May 26 2022 - 4:19PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
SCHEDULE
13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
Zymeworks
Inc.
______________________________________________________________________________
(Name of Issuer)
Common Shares, no par value per share
______________________________________________________________________________
(Title of Class of Securities)
98985W102
______________________________________________________________________________
(CUSIP Number of Class of Securities)
Daniel Cookson
All Blue Falcons FZE
Office 2301
23rd Floor API Trio Tower
Al Barsha 1
Dubai, United Arab Emirates
+971555241459
_____________________________________________________________________________________
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
May 26, 2022
______________________________________________________________________________
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a Statement
on Schedule 13G to report the acquisition that is the subject of this Schedule 13D and is filing this Schedule because of Rule 13d-1(e),
13d-1(f) or 13d-1(g), check the following box. ¨
Note: Schedules filed in paper format shall include
a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7(b) for other parties to whom copies are
to be sent.
*The remainder of this cover page shall be filled
out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this
cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
SCHEDULE 13D
CUSIP No. 98985W102 |
|
Page 2 of 5 Pages |
1 |
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
All Blue Falcons FZE |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY |
4 |
SOURCE OF FUNDS (See Instructions)
OO |
5 |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |
¨ |
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United Arab Emirates |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
7 |
SOLE VOTING POWER
3,989,4981 |
8 |
SHARED VOTING POWER
0 |
9 |
SOLE DISPOSITIVE POWER
3,989,4981 |
10 |
SHARED DISPOSITIVE POWER
0 |
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,989,4981 |
12 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) |
¨ |
13 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
6.91%2 |
14 |
TYPE OF REPORTING PERSON (See Instructions)
OO |
| 1 | Represents the sum of (i) 3,709,498 Shares directly beneficially owned by All Blue Falcons FZE as of the
date hereof and (ii) 280,000 Shares underlying call options as described below in Item 5 of this Schedule 13D. |
| 2 | Based on 57,771,204 Shares issued and outstanding as of May
2, 2022, as disclosed in the Quarterly Report on Form 10-Q filed by the Company with the SEC on May 4, 2022 (the “Form 10-Q”). |
SCHEDULE 13D
CUSIP No. 98985W102 |
|
Page
3 of 5 Pages |
1 |
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Daniel Edward Llewellen Cookson |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY |
4 |
SOURCE OF FUNDS (See Instructions)
|
5 |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |
¨ |
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United Kingdom |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
7 |
SOLE VOTING POWER
3,989,4983 |
8 |
SHARED VOTING POWER
0 |
9 |
SOLE DISPOSITIVE POWER
3,989,4983 |
10 |
SHARED DISPOSITIVE POWER
0 |
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,989,4983 |
12 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) |
¨ |
13 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
6.91%4 |
14 |
TYPE OF REPORTING PERSON (See Instructions)
HC; IN |
| 3 | Represents the sum of (i) 3,709,498 Shares directly beneficially
owned by All Blue Falcons FZE as of the date hereof and (ii) 280,000 Shares underlying call options as described below in Item 5 of this
Schedule 13D. |
| 4 | Based on 57,771,204 Shares issued and outstanding as of May
2, 2022, as disclosed in the Form 10-Q. |
AMENDMENT NO. 3 TO SCHEDULE 13D
This Amendment No. 3 to Schedule
13D (this “Amendment”) is being filed by All Blue Falcons FZE, a company organized in the Ras Al Kaihamh Economic Zone
of the Emirate of Ras Al Khaimah in the United Arab Emirates (“All Blue Falcons”), and Daniel Edward Llewellen Cookson
(“Mr. Cookson”) (collectively, the “Reporting Persons”) to amend the Schedule 13D originally filed
with the Securities and Exchange Commission (the “SEC”) on April 22, 2022, as amended by Amendment No. 1 to Schedule
13D filed on April 28, 2022, and Amendment No. 2 to Schedule 13D filed on May 20, 2022 (as amended and supplemented, the “Original
Statement” and, as amended and supplemented by this Amendment, the “Statement”), relating to the common shares,
no par value (the “Shares”), of Zymeworks Inc., a corporation organized under the laws of the province of British Columbia
under the Business Corporations Act (British Columbia) (the “Issuer”). Capitalized terms used herein but not
defined have the respective meanings ascribed to them in the Original Statement.
| ITEM 2. | Identity and Background |
Item 2(a)(i) and (ii) of the Original Statement
is hereby amended and restated in its entirety as follows:
“(a) This Schedule 13D is filed jointly
by the following persons (each, a “Reporting Person” and, collectively, the “Reporting Persons”):
| (i) | All Blue Falcons FZE, a company organized in the Ras Al Khaimah Economic Zone of the Emirate of Ras Al
Khaimah in the United Arab Emirates (“All Blue Falcons”). All Blue Falcons is the direct beneficial owner of 3,989,498
Shares; and |
| (ii) | Daniel Edward Llewellen Cookson, a United Kingdom citizen. Mr. Cookson is the sole shareholder and a Director
of All Blue Falcons. By virtue of his position as a control person of All Blue Falcons, Mr. Cookson may be deemed to beneficially own
the 3,989,498 Shares directly held by All Blue Falcons. |
| ITEM 3. | Source and Amount of Funds or Other Consideration |
Item 3 of the Original Statement is hereby amended
and restated in its entirety as follows:
“The 3,709,498 Shares beneficially owned
in the aggregate by the Reporting Persons and the call options to purchase 280,000 Shares referenced in Item 5 were acquired in open market
transactions. The Reporting Persons expended an aggregate of approximately $45,461,822 to acquire the 3,709,498 Shares reported as beneficially
owned by them in this Schedule 13D and the call options to purchase 280,000 Shares referenced in Item 5, which purchases were made out
of working capital. No part of the purchase price is or will be represented by funds or other consideration borrowed or otherwise obtained
for the purpose of acquiring, holding, trading or voting the securities.”
| ITEM 5. | INTEREST IN SECURITIES OF THE ISSUER |
Item 5(a) and (b) of the Original Statement is hereby amended and restated
in its entirety as follows:
“(a) and (b)
All percentages of Shares outstanding contained
herein are based on 57,771,204 Shares issued and outstanding as of May 2, 2022, as disclosed in the Quarterly Report on Form 10-Q filed
by the Company with the SEC on May 4, 2022.
As of the date hereof, each of the Reporting Persons
may be deemed to have beneficial ownership of 3,989,498 Shares, representing 6.91% of the outstanding Shares. The 3,989,498 Shares equal
the sum of (i) 3,709,498 Shares directly beneficially owned by All Blue Falcons as of the date hereof and (ii) 280,000 Shares underlying
the call options referenced below in this Item 5. All Blue Falcons may be deemed to have the sole power to vote or direct the vote and
dispose or direct the disposition of all of the 3,989,498 Shares, while Mr. Cookson may be deemed to beneficially own all of the 3,989,498
Shares by virtue of his position as a control person of All Blue Falcons.
The call options referenced above are American-style
call options to purchase an aggregate of 200,000 Shares at an exercise price of $15.00 per Share and an aggregate of 80,000 Shares at
an exercise price of $5.00 per Share. All of these call options expire on December 16, 2022.”
Item 5(c) of the Original Statement is hereby
amended and supplemented by adding the following information:
“(c) Schedule II hereto sets forth all transactions with respect
to the Shares effected by the Reporting Persons since the Original Statement. All such transactions were effected in the open market,
and per share prices do not include any commissions paid in connection with such transactions.”
SIGNATURE
After reasonable inquiry and
to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: May 26, 2022
|
ALL BLUE FALCONS FZE |
|
|
|
|
By: |
/s/ Daniel Cookson |
|
|
Daniel Cookson, Director |
|
|
|
|
/s/ Daniel Cookson |
|
Daniel Cookson |
SCHEDULE II
Reporting Person | |
Nature of Transaction | |
Trade Date | |
Amount of
Securities
Purchased
(Sold) | | |
Price per
Share/Premium
per Option | |
All Blue Falcons FZE | |
Purchase of Shares | |
05/23/2022 | |
| 100,000 | | |
$ | 6.11913 | |
All Blue Falcons FZE | |
Purchase of Shares | |
05/24/2022 | |
| 100,000 | | |
$ | 5.7993 | |
All Blue Falcons FZE | |
Purchase of Shares | |
05/25/2022 | |
| 100,000 | | |
$ | 5.9088 | |
All Blue Falcons FZE | |
Purchase of Shares | |
05/26/2022 | |
| 270,000 | | |
$ | 6.4498 | |
Zymeworks (NYSE:ZYME)
Historical Stock Chart
From Mar 2024 to Apr 2024
Zymeworks (NYSE:ZYME)
Historical Stock Chart
From Apr 2023 to Apr 2024